Ajanta Pharma Ltd consolidated Q1FY26 PAT up at Rs. 255.34 crores

Ajanta Pharma Limited has reported Consolidated financial results for the period ended June 30, 2025.

Financial Results (Q1 FY2026) - QoQ Comparison

The company has reported total income of Rs. 1328.98 crores during the period ended June 30, 2025 as compared to Rs. 1188.52 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs. 255.34 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs. 225.26 crores for the period ended March 31, 2025.

The company has reported EPS of Rs. 20.43 for the period ended June 30, 2025 as compared to Rs. 18 for the period ended March 31, 2025.

Financials	Q1 FY2026	Q4 FY2025	% Change
Total Income	₹ 1328.98 crs	₹1188.52 crs	11.82%
Net Profit	₹255.34 crs	₹225.26 crs	13.35%
EPS	₹20.43	₹18	13.50%

Financial Results (Q1 FY2026) - YoY Comparison

The company has reported total income of Rs. 1328.98 crores during the period ended June 30, 2025 as compared to Rs.1171.39 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs.255.34 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs.245.77 crores for the period ended June 30, 2024.

The company has reported EPS of Rs.20.43 for the period ended June 30, 2025 as compared to Rs.19.53 for the period ended June 30, 2024.

Financials	Q1 FY2026	Q1 FY2025	% Change
Total Income	₹ 1328.98 crs	₹1171.39 crs	13.45%
Net Profit	₹255.34 crs	₹245.77 crs	3.89%
EPS	₹20.43	₹19.53	4.61%

Shares of Ajanta Pharma Limited was last trading in BSE at Rs. 2771.45 as compared to the previous close of Rs. 2781.30. The total number of shares traded during the day was 4206 in over 964 trades.

The stock hit an intraday high of Rs. 2829.55 and intraday low of 2727.05. The net turnover during the day was Rs. 11685788.00.

Source : Equity Bulls

Keywords

AjantaPharma Q1FY26 Q1FY2026 FY2026 ResultUpdate